About the Company
the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. strategic alliances building on its strengths in innovative small molecule drug discovery and development, infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline. business and scientific expertise the company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $INFI News
Infinity Pharmaceuticals Inc INFIQ
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Infinity Pharmaceuticals Inc. (INFI)
Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...
Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first ...
Biotech bankruptcies hit a record despite sector’s recovery
Failure to obtain shareholder approval for its proposed merger agreement with MEI Pharma (MEIP) sent Infinity Pharmaceuticals (OTC:INFIQ) underwater in September. Other notable biotech bankruptcies in ...
Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know
Infinity Pharmaceuticals (INFI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2022. This widely-known ...
Infinity Pharmaceuticals
This page shows the latest Infinity Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare. Bristol-Myers Squibb and Infinity Pharmaceuticals have teamed up to ...
David Schnell's Net Worth
Trubion Pharmaceuticals, Inc, INFINITY PHARMACEUTICALS, INC., SENOMYX INC, and BAXANO SURGICAL, INC.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with ...
MRNS Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure ...
Infinity Pharmaceuticals, Inc. (INFIQ)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Infinity Pharmaceuticals, Inc. (INFIQ)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Infinity Pharmaceuticals Inc. (INFIQ)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Loading the latest forecasts...